200 related articles for article (PubMed ID: 21304968)
1. Cytosolic guanine nucledotide binding deficient form of transglutaminase 2 (R580a) potentiates cell death in oxygen glucose deprivation.
Colak G; Keillor JW; Johnson GV
PLoS One; 2011 Jan; 6(1):e16665. PubMed ID: 21304968
[TBL] [Abstract][Full Text] [Related]
2. Intracellular localization and conformational state of transglutaminase 2: implications for cell death.
Gundemir S; Johnson GV
PLoS One; 2009 Jul; 4(7):e6123. PubMed ID: 19568436
[TBL] [Abstract][Full Text] [Related]
3. Transglutaminase 2 facilitates or ameliorates HIF signaling and ischemic cell death depending on its conformation and localization.
Gundemir S; Colak G; Feola J; Blouin R; Johnson GV
Biochim Biophys Acta; 2013 Jan; 1833(1):1-10. PubMed ID: 23085038
[TBL] [Abstract][Full Text] [Related]
4. Transglutaminase 2: a molecular Swiss army knife.
Gundemir S; Colak G; Tucholski J; Johnson GV
Biochim Biophys Acta; 2012 Feb; 1823(2):406-19. PubMed ID: 22015769
[TBL] [Abstract][Full Text] [Related]
5. Evidence that GTP-binding domain but not catalytic domain of transglutaminase 2 is essential for epithelial-to-mesenchymal transition in mammary epithelial cells.
Kumar A; Xu J; Sung B; Kumar S; Yu D; Aggarwal BB; Mehta K
Breast Cancer Res; 2012 Jan; 14(1):R4. PubMed ID: 22225906
[TBL] [Abstract][Full Text] [Related]
6. Transglutaminase 2 protects against ischemic insult, interacts with HIF1beta, and attenuates HIF1 signaling.
Filiano AJ; Bailey CD; Tucholski J; Gundemir S; Johnson GV
FASEB J; 2008 Aug; 22(8):2662-75. PubMed ID: 18375543
[TBL] [Abstract][Full Text] [Related]
7. Using FLIM-FRET to measure conformational changes of transglutaminase type 2 in live cells.
Caron NS; Munsie LN; Keillor JW; Truant R
PLoS One; 2012; 7(8):e44159. PubMed ID: 22952912
[TBL] [Abstract][Full Text] [Related]
8. Complete transglutaminase 2 ablation results in reduced stroke volumes and astrocytes that exhibit increased survival in response to ischemia.
Colak G; Johnson GV
Neurobiol Dis; 2012 Mar; 45(3):1042-50. PubMed ID: 22198379
[TBL] [Abstract][Full Text] [Related]
9. The Differential Effects of R580A Mutation on Transamidation and GTP Binding Activity of Rat and Human Type 2 Transglutaminase.
Ruan Q; Tucholski J; Gundemir S; Johnson Voll GV
Int J Clin Exp Med; 2008; 1(3):248-59. PubMed ID: 19079660
[TBL] [Abstract][Full Text] [Related]
10. Transglutaminase 2: Friend or foe? The discordant role in neurons and astrocytes.
Quinn BR; Yunes-Medina L; Johnson GVW
J Neurosci Res; 2018 Jul; 96(7):1150-1158. PubMed ID: 29570839
[TBL] [Abstract][Full Text] [Related]
11. Depletion of astrocytic transglutaminase 2 improves injury outcomes.
Monteagudo A; Feola J; Natola H; Ji C; Pröschel C; Johnson GVW
Mol Cell Neurosci; 2018 Oct; 92():128-136. PubMed ID: 29969654
[TBL] [Abstract][Full Text] [Related]
12. Transamidase site-targeted agents alter the conformation of the transglutaminase cancer stem cell survival protein to reduce GTP binding activity and cancer stem cell survival.
Kerr C; Szmacinski H; Fisher ML; Nance B; Lakowicz JR; Akbar A; Keillor JW; Lok Wong T; Godoy-Ruiz R; Toth EA; Weber DJ; Eckert RL
Oncogene; 2017 May; 36(21):2981-2990. PubMed ID: 27941875
[TBL] [Abstract][Full Text] [Related]
13. Functional characterization of naturally occurring transglutaminase 2 mutants implicated in early-onset type 2 diabetes.
Salter NW; Ande SR; Nguyen HK; Nyomba BL; Mishra S
J Mol Endocrinol; 2012 Jun; 48(3):203-16. PubMed ID: 22394545
[TBL] [Abstract][Full Text] [Related]
14. Tissue transglutaminase is a multifunctional BH3-only protein.
Rodolfo C; Mormone E; Matarrese P; Ciccosanti F; Farrace MG; Garofano E; Piredda L; Fimia GM; Malorni W; Piacentini M
J Biol Chem; 2004 Dec; 279(52):54783-92. PubMed ID: 15485857
[TBL] [Abstract][Full Text] [Related]
15. Transglutaminase 2: a multi-functional protein in multiple subcellular compartments.
Park D; Choi SS; Ha KS
Amino Acids; 2010 Aug; 39(3):619-31. PubMed ID: 20148342
[TBL] [Abstract][Full Text] [Related]
16. Physiological, pathological, and structural implications of non-enzymatic protein-protein interactions of the multifunctional human transglutaminase 2.
Kanchan K; Fuxreiter M; Fésüs L
Cell Mol Life Sci; 2015 Aug; 72(16):3009-35. PubMed ID: 25943306
[TBL] [Abstract][Full Text] [Related]
17. Transglutaminase 2 modulation of NF-κB signaling in astrocytes is independent of its ability to mediate astrocytic viability in ischemic injury.
Feola J; Barton A; Akbar A; Keillor J; Johnson GVW
Brain Res; 2017 Aug; 1668():1-11. PubMed ID: 28522262
[TBL] [Abstract][Full Text] [Related]
18. TG2 transamidating activity acts as a reostat controlling the interplay between apoptosis and autophagy.
Rossin F; D'Eletto M; Macdonald D; Farrace MG; Piacentini M
Amino Acids; 2012 May; 42(5):1793-802. PubMed ID: 21479826
[TBL] [Abstract][Full Text] [Related]
19. Role of Transglutaminase 2 in Cell Death, Survival, and Fibrosis.
Tatsukawa H; Hitomi K
Cells; 2021 Jul; 10(7):. PubMed ID: 34360011
[TBL] [Abstract][Full Text] [Related]
20. Detection of Transglutaminase 2 conformational changes in living cell.
Pavlyukov MS; Antipova NV; Balashova MV; Shakhparonov MI
Biochem Biophys Res Commun; 2012 May; 421(4):773-9. PubMed ID: 22548802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]